Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386284003> ?p ?o ?g. }
Showing items 1 to 92 of
92
with 100 items per page.
- W4386284003 abstract "Abstract Background High-risk stage III colon cancer has a considerably poorer prognosis than stage II and low-risk stage III colon cancers. Nevertheless, most guidelines recommend similar adjuvant treatment approaches for all these stages despite the dearth of research focusing on high-risk stage III colon cancer and the potential for improved prognosis with intensive adjuvant treatment. Given the the proven efficacy of triplet chemotherapy in metastatic colorectal cancer treatment, the goal of this study is to evaluate the oncologic efficacy and safety of mFOLFIRINOX in comparison to those of the current standard of care, mFOLFOX 6, as an adjuvant treatment for patients diagnosed with high-risk stage III colon cancer after radical resection. Methods This multicenter, randomized (1:1), open-label, phase II trial will assess and compare the effectiveness and toxicity of mFOLFIRINOX and mFOLFOX 6 in patients with high-risk stage III colon cancer after radical resection. The goal of the trial is to enroll 312 eligible patients, from 11 institutes, aged between 20 and 70 years, with an Eastern Cooperative Oncology Group (ECOG) performance status of 0–2, or between 70 and 75 with an ECOG performance status of 0. Patients will be randomized into two arms - Arm A, the experimental arm, and Arm B, the reference arm - and will receive 12 cycles of mFOLFIRINOX and mFOLFOX 6 every 2 weeks, respectively. The primary endpoint of this study is the 3-year disease-free survival, and secondary endpoints include the 3-year overall survival and treatment toxicity. Discussion: The Frost trial would help determine the oncologic efficacy and safety of adjuvant triplet chemotherapy for high-risk stage III colon cancers and ultimately improve prognoses. Trial registration: ClinicalTrials.gov NCT05179889, registered on 17 December 2021." @default.
- W4386284003 created "2023-08-31" @default.
- W4386284003 creator A5009947364 @default.
- W4386284003 creator A5015230939 @default.
- W4386284003 creator A5020214792 @default.
- W4386284003 creator A5033866952 @default.
- W4386284003 creator A5047881617 @default.
- W4386284003 creator A5054475299 @default.
- W4386284003 creator A5060872234 @default.
- W4386284003 creator A5073291005 @default.
- W4386284003 creator A5074905344 @default.
- W4386284003 creator A5077668811 @default.
- W4386284003 creator A5082317667 @default.
- W4386284003 creator A5084010136 @default.
- W4386284003 creator A5084305870 @default.
- W4386284003 creator A5089573273 @default.
- W4386284003 date "2023-08-30" @default.
- W4386284003 modified "2023-09-27" @default.
- W4386284003 title "mFOLFIRINOX versus mFOLFOX 6 as adjuvant treatment for high-risk stage III colon cancer - The FROST trial: Study protocol for a multicenter, randomized controlled, phase II trial" @default.
- W4386284003 cites W2037339308 @default.
- W4386284003 cites W2098499757 @default.
- W4386284003 cites W2118950501 @default.
- W4386284003 cites W2121113526 @default.
- W4386284003 cites W2125857654 @default.
- W4386284003 cites W2132352600 @default.
- W4386284003 cites W2138985803 @default.
- W4386284003 cites W2141665958 @default.
- W4386284003 cites W2159342260 @default.
- W4386284003 cites W2171232394 @default.
- W4386284003 cites W2578423617 @default.
- W4386284003 cites W2795004907 @default.
- W4386284003 cites W2898075990 @default.
- W4386284003 doi "https://doi.org/10.21203/rs.3.rs-3222244/v1" @default.
- W4386284003 hasPublicationYear "2023" @default.
- W4386284003 type Work @default.
- W4386284003 citedByCount "0" @default.
- W4386284003 crossrefType "posted-content" @default.
- W4386284003 hasAuthorship W4386284003A5009947364 @default.
- W4386284003 hasAuthorship W4386284003A5015230939 @default.
- W4386284003 hasAuthorship W4386284003A5020214792 @default.
- W4386284003 hasAuthorship W4386284003A5033866952 @default.
- W4386284003 hasAuthorship W4386284003A5047881617 @default.
- W4386284003 hasAuthorship W4386284003A5054475299 @default.
- W4386284003 hasAuthorship W4386284003A5060872234 @default.
- W4386284003 hasAuthorship W4386284003A5073291005 @default.
- W4386284003 hasAuthorship W4386284003A5074905344 @default.
- W4386284003 hasAuthorship W4386284003A5077668811 @default.
- W4386284003 hasAuthorship W4386284003A5082317667 @default.
- W4386284003 hasAuthorship W4386284003A5084010136 @default.
- W4386284003 hasAuthorship W4386284003A5084305870 @default.
- W4386284003 hasAuthorship W4386284003A5089573273 @default.
- W4386284003 hasBestOaLocation W43862840031 @default.
- W4386284003 hasConcept C121608353 @default.
- W4386284003 hasConcept C126322002 @default.
- W4386284003 hasConcept C143998085 @default.
- W4386284003 hasConcept C146357865 @default.
- W4386284003 hasConcept C151730666 @default.
- W4386284003 hasConcept C168563851 @default.
- W4386284003 hasConcept C203092338 @default.
- W4386284003 hasConcept C2777863537 @default.
- W4386284003 hasConcept C526805850 @default.
- W4386284003 hasConcept C535046627 @default.
- W4386284003 hasConcept C71924100 @default.
- W4386284003 hasConcept C86803240 @default.
- W4386284003 hasConceptScore W4386284003C121608353 @default.
- W4386284003 hasConceptScore W4386284003C126322002 @default.
- W4386284003 hasConceptScore W4386284003C143998085 @default.
- W4386284003 hasConceptScore W4386284003C146357865 @default.
- W4386284003 hasConceptScore W4386284003C151730666 @default.
- W4386284003 hasConceptScore W4386284003C168563851 @default.
- W4386284003 hasConceptScore W4386284003C203092338 @default.
- W4386284003 hasConceptScore W4386284003C2777863537 @default.
- W4386284003 hasConceptScore W4386284003C526805850 @default.
- W4386284003 hasConceptScore W4386284003C535046627 @default.
- W4386284003 hasConceptScore W4386284003C71924100 @default.
- W4386284003 hasConceptScore W4386284003C86803240 @default.
- W4386284003 hasLocation W43862840031 @default.
- W4386284003 hasOpenAccess W4386284003 @default.
- W4386284003 hasPrimaryLocation W43862840031 @default.
- W4386284003 hasRelatedWork W2349999257 @default.
- W4386284003 hasRelatedWork W2356105190 @default.
- W4386284003 hasRelatedWork W2392730113 @default.
- W4386284003 hasRelatedWork W2427058397 @default.
- W4386284003 hasRelatedWork W2729289325 @default.
- W4386284003 hasRelatedWork W3004259476 @default.
- W4386284003 hasRelatedWork W3089163820 @default.
- W4386284003 hasRelatedWork W3159250744 @default.
- W4386284003 hasRelatedWork W4256514411 @default.
- W4386284003 hasRelatedWork W4292236216 @default.
- W4386284003 isParatext "false" @default.
- W4386284003 isRetracted "false" @default.
- W4386284003 workType "article" @default.